ISR Isoray Inc

IsoRay Inc offers solutions for the treatment and diagnosis of disease using medical isotopes. The Company treats prostate cancer, brain, liver, breast cancer, colorectal cancer, gynecological cancer, lung cancer, ocular melanoma and pancreatic cancer.

$0.30  +0.02 (7.22%)
As of 09/28/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  11/02/2005
Outstanding shares:  142,040,266
Average volume:  171,720
Market cap:   $40,765,556
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -6.47
PB ratio:   0.64
PS ratio:   3.71
Return on equity:   -9.90%
Net income %:   -56.86%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy